What is Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)?
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a rare autoimmune disorder in which a person’s own immune system mounts an inflammatory response and causes damage to his or her peripheral nerves. This can affect the sensory, motor and autonomic nerves. Symptoms often come on gradually and can include sensory disturbances in the extremities (hands, arms, feet and legs), muscle weakness and loss of reflexes.
CIDP patients can be treated with intravenous immunoglobulins (IVIG), plasmapheresis (PE) or steroid treatment. Many patients can have a long recovery, can experience recurrence and progression of symptoms, and are left with permanent residual symptoms, including sensory disturbances in their extremities, nerve and muscle pain, weakness and extreme fatigue.
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is similar to Guillain-Barre Syndrome (GBS), which also affects the peripheral nerves, but is distinguished by the acute onset of symptoms and monophasic nature of GBS.